|
VIDA study |
22/06/2020 |
CIGB |
|
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 |
22/05/2020 |
FINLAY |
|
Usual treatment plus intra-articular application of bioactive formulation for osteoarthritis |
11/06/2018 |
SSA |
|
TS-FARMEV Study |
2011-05-16 |
CIGB |
|
Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab |
12/05/2020 |
CIM |
|
Treatment for maxillary cysts |
30/05/2018 |
SSA |
|
Totally Laparoscopic Hysterectomy with Single-Port Access. Validation of a new technique in Cuba. |
22/04/2014 |
CNCMA |
|
Tisuacryl® in Dental Hyperesthesia |
2008-09-18 |
BIOMAT |
|
THERESA-5 Study |
08/04/2015 |
CIGB |
|
THERESA-3 Study |
2009-12-11 |
CIGB |
|
Therapeutic clinical evaluation of the Plectranthus amboinicus Lour Spreng (Oregano French) tablets in patient with common cold |
2011-11-22 |
CIDEM |
|
SURFACEN in ARDS. Adults. Phase IV |
24/06/2015 |
CENSA |
|
Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II |
14/06/2018 |
BIOCEN |
|
Stem cells in patients with lung lesions (COVID-19) |
03/07/2020 |
IHI |
|
Stem cell assisted centrifugal fat transfer |
26/03/2021 |
HHA |
|
SOBERANA PEDIATRIA CLINICA 1 |
23/07/2021 |
FINLAY |
|
SOBERANA 01 |
13/08/2020 |
FINLAY |
|
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension |
29/09/2017 |
CENSA |
|
rTMS-stroke-phase I |
2009-05-29 |
CIREN |
|
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma |
05/11/2013 |
CIM |
